Osteoporosis-pseudoglioma syndrome (OPPG)

LRP5 - osteoporosis-pseudoglioma syndrome

This test is available for the following conditions:

• Conditions > Skeletal > Osteoporosis-pseudoglioma syndrome (OPPG)
• Conditions > Vision impairment / blindness > Osteoporosis-pseudoglioma syndrome (OPPG)

This product is also part of the following panels:

• WES comprehensive preconception carrier test ¹
• WES hearing impairment (including GJB2) (100.0% *)
• WES liver disorders (100.0% *)
• WES Mendelian inherited disorders (100.0% *)
• WES renal disorders (100.0% *)
• WES renal disorders (100.0% *)
• WES short stature/skeletal dysplasia (100.0% *)
• WES vision disorders (100.0% *)

* % of the coding region of this gene has a coverage of >20x. (Without % information : This is a non-coding gene for which coverage statistics could not be determined)

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks

Method

• Sequence analysis of all coding exons and flanking intron-exon boundaries

OMIM: 603506
Performing laboratory: Radboudumc
Authorized material(s): EDTA blood, Isolated DNA, Buccal mucous membrane

---